Terms: = Colorectal cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
64 results:
1. Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Hao J; Liu C; Gu Z; Yang X; Lan X; Guo X
Nat Commun; 2024 Apr; 15(1):2820. PubMed ID: 38561332
[TBL] [Abstract] [Full Text] [Related]
2. Precursor exhausted CD8
Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
[TBL] [Abstract] [Full Text] [Related]
3. The New Role of
Zhang X; Wu T; Qin R; Cai X; Zhou Y; Wang X; Shang Z; Li G; Yang R; Dong C; Li J; Ren Y; Ding R; Li Y
Front Biosci (Landmark Ed); 2023 Nov; 28(11):301. PubMed ID: 38062804
[TBL] [Abstract] [Full Text] [Related]
4. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
Yakou MH; Ghilas S; Tran K; Liao Y; Afshar-Sterle S; Kumari A; Schmid K; Dijkstra C; Inguanti C; Ostrouska S; Wilcox J; Smith M; Parathan P; Allam A; Xue HH; Belz GT; Mariadason JM; Behren A; Drummond GR; Ruscher R; Williams DS; Pal B; Shi W; Ernst M; Raghu D; Mielke LA
Sci Immunol; 2023 Oct; 8(88):eadf2163. PubMed ID: 37801516
[TBL] [Abstract] [Full Text] [Related]
5. LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway.
Zhuang Y; Ning C; Liu P; Zhao Y; Li Y; Ma Z; Shan L; Piao Y; Zhao P; Jin X
Oncol Res; 2022; 30(6):289-300. PubMed ID: 37303493
[TBL] [Abstract] [Full Text] [Related]
6. hnf1a regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
Xia R; Hu C; Ye Y; Zhang X; Li T; He R; Zheng S; Wen X; Chen R
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36825600
[TBL] [Abstract] [Full Text] [Related]
7. Concurrent inactivating mutations and expression losses of RGS2, hnf1a, and CAPN12 candidate tumor suppressor genes in colon cancers.
Kim JW; Moon SW; Mo HY; Son HJ; Choi EJ; Yoo NJ; Ann CH; Lee SH
Pathol Res Pract; 2023 Jan; 241():154288. PubMed ID: 36566600
[TBL] [Abstract] [Full Text] [Related]
8. m
Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
[TBL] [Abstract] [Full Text] [Related]
9. hnf1a-AS1: A Tumor-associated Long Non-coding RNA.
Liu Y; Zhao F; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(21):1720-1729. PubMed ID: 35619319
[TBL] [Abstract] [Full Text] [Related]
10. colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
Larsen PT; Jørgensen SF; Njor SH
BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
[TBL] [Abstract] [Full Text] [Related]
11. High Diversity of Glycosphingolipid Glycans of colorectal cancer Cell Lines Reflects the Cellular Differentiation Phenotype.
Wang D; Madunić K; Zhang T; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
Mol Cell Proteomics; 2022 Jun; 21(6):100239. PubMed ID: 35489554
[TBL] [Abstract] [Full Text] [Related]
12. Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer.
Xu Y; Wang H; Wang T; Chen C; Sun R; Yao W; Ma Y; Zhang Q; Wu L; Zeng S; Sun X
Cancer Sci; 2022 May; 113(5):1739-1751. PubMed ID: 35238098
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression of hnf1a and hnf1a-AS1 in colon cancer cells.
Sepehri Z; Banerjee A; Vizeacoumar FS; Freywald A; Vizeacoumar FJ; Dolinsky VW; Davie JR
IUBMB Life; 2022 Jun; 74(6):496-507. PubMed ID: 35184384
[TBL] [Abstract] [Full Text] [Related]
14. Hepatocyte nuclear factor hnf1a is a potential regulator in shaping the super-enhancer landscape in colorectal cancer liver metastasis.
Cai C; Bi D; Bick G; Wei Q; Liu H; Lu L; Zhang X; Qin H
FEBS Lett; 2021 Dec; 595(24):3056-3071. PubMed ID: 34719039
[TBL] [Abstract] [Full Text] [Related]
15. hnf1a regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Michael M; Liauw W; McLachlan SA; Link E; Matera A; Thompson M; Jefford M; Hicks RJ; Cullinane C; Hatzimihalis A; Campbell IG; Rowley S; Beale PJ; Karapetis CS; Price T; Burge ME
Cancer Chemother Pharmacol; 2021 Jul; 88(1):39-52. PubMed ID: 33755789
[TBL] [Abstract] [Full Text] [Related]
17. Wnt-β-catenin activation epigenetically reprograms T
Quandt J; Arnovitz S; Haghi L; Woehlk J; Mohsin A; Okoreeh M; Mathur PS; Emmanuel AO; Osman A; Krishnan M; Morin SB; Pearson AT; Sweis RF; Pekow J; Weber CR; Khazaie K; Gounari F
Nat Immunol; 2021 Apr; 22(4):471-484. PubMed ID: 33664518
[TBL] [Abstract] [Full Text] [Related]
18. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
20. Slow-Cycling cancer Stem Cells Regulate Progression and Chemoresistance in Colon cancer.
Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
[TBL] [Abstract] [Full Text] [Related]
[Next]
